Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model

DOI10.1111/BIOM.12281zbMath1390.62245OpenAlexW2122192985WikidataQ41587108 ScholiaQ41587108MaRDI QIDQ3459944

A. S. C. Conlon, Daniel J. Sargent

Publication date: 11 January 2016

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc4480062

zbMATH Keywords

auxiliary variablecure modelsmultiple imputationmulti-state modelcolon cancerKaplan-Meier estimates

Mathematics Subject Classification ID

Estimation in multivariate analysis (62H12) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (1)

A Bayesian multi‐risks survival (MRS) model in the presence of double censorings

Cites Work

• Unnamed Item
• Unnamed Item
• A Shrinkage Approach for Estimating a Treatment Effect Using Intermediate Biomarker Data in Clinical Trials
• A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
• Multiple Imputation After 18+ Years
• Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
• Using Auxiliary Variables for Improved Estimates of Survival Time
• Using surrogate failure time data to increase cost effectiveness in clinical trials
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Some comments on efficiency gains from auxiliary information for right-censored data

This page was built for publication: Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model